https://www.selleckchem.com/products/ms-275.html
GPI were associated with a 2-fold increase in the probability of achieving TIMI 3 flow (pooled OR, 2.05; 95% CI 1.37-3.05; I = 37%, P = 0.0004). Major bleeding events were not increased with GPI therapy (pooled OR, 1.0; 95% CI 0.55-1.83; I = 1%, P = 0.99). Meta-regression identified that patients not receiving an intra-aortic balloon pump seemed to benefit the most from GPI use (Z = - 1.57, P = 0.005). GPI therapy as an adjunct to standard treatment in cardiogenic shock was associated with better outcomes, including both short- and long-
Aimer
Commentaire
Partagez
